文献速递胸部肿瘤

DNA甲基化作为恶性间皮瘤诊断生物标志物的系统综述与Meta分析

DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Thorac Oncol · 2021-05-31

结果显示APC基因在间皮瘤中显著低甲基化,CDH1、ESR1、miR-34b/c、PGR、RARβ、SFRP1和WIF1显著高甲基化。APC、miR-34b/c和WIF1为最适候选生物标志物,但研究数量与对象有限,尚不能得出临床应用结论。

要点

  • APC在间皮瘤中显著低甲基化,CDH1、ESR1、miR-34b/c、PGR、RARβ、SFRP1、WIF1显著高甲基化
  • APC、miR-34b/c和WIF1为最适候选诊断生物标志物
  • 研究数量与对象有限,尚不能得出临床应用结论

核心结论

  • APC基因在间皮瘤中显著低甲基化,CDH1、ESR1、miR-34b/c、PGR、RARβ、SFRP1和WIF1显著高甲基化。
  • APC、miR-34b/c和WIF1是Meta分析中最适候选生物标志物,但研究数量与对象有限,尚不能得出临床应用结论。

主要发现

  • Meta分析中APC基因在间皮瘤中显著低甲基化。
  • Meta分析中CDH1、ESR1、miR-34b/c、PGR、RARβ、SFRP1和WIF1在间皮瘤中显著高甲基化。
  • Meta分析纳入的13个基因为APC、CDH1、CDKN2A、DAPK、ESR1、MGMT、miR-34b/c、PGR、RARβ、RASSF1、SFRP1、SFRP4、WIF1。

临床怎么用

  • APC、miR-34b/c和WIF1可作为间皮瘤诊断候选生物标志物进一步验证。
  • 未来需采用标准化全基因组甲基化分析方法阐明间皮瘤全基因组DNA甲基化谱。

局限性

  • Meta分析纳入的研究数量和研究对象均太少,无法对其临床应用得出最终结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Malignant mesothelioma is an aggressive cancer type linked to asbestos exposure. Because of several intrinsic challenges, mesothelioma is often diagnosed in an advanced disease stage. Therefore, there is a need for diagnostic biomarkers that may contribute to early detection. Recently, the epigenome of tumors is being extensively investigated to identify biomarkers. This manuscript is a systematic review summarizing the state-of-the-art research investigating DNA methylation in mesothelioma. Four literature databases (PubMed, Scopus, Web of Science, MEDLINE) were systematically searched for studies investigating DNA methylation in mesothelioma up to October 16, 2020. A meta-analysis was performed per gene investigated in at least two independent studies. A total of 53 studies investigated DNA methylation of 97 genes in mesothelioma and are described in a qualitative overview. Furthermore, ten studies investigating 13 genes (APC, CDH1, CDKN2A, DAPK, ESR1, MGMT, miR-34b/c, PGR, RARβ, RASSF1, SFRP1, SFRP4, WIF1) were included in the quantitative meta-analysis. In this meta-analysis, the APC gene is significantly hypomethylated in mesothelioma, whereas CDH1, ESR1, miR-34b/c, PGR, RARβ, SFRP1, and WIF1 are significantly hypermethylated in mesothelioma. The three genes that are the most appropriate candidate biomarkers from this meta-analysis are APC, miR-34b/c, and WIF1. Nevertheless, both study number and study objects comprised in this meta-analysis are too low to draw final conclusions on their clinical applications. The elucidation of the genome-wide DNA methylation profile of mesothelioma is desirable in the future, using a standardized genome-wide methylation analysis approach. The most informative CpG sites from this signature could then form the basis of a panel of highly sensitive and specific biomarkers that can be used for the diagnosis of mesothelioma and even for the screening of an at high-risk population of asbestos-exposed individuals.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Vandenhoeck J, van Meerbeeck JP, Fransen E, et al. DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2021. PMID: 34082107. doi:10.1016/j.jtho.2021.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。